All stock lists
Allogene Therapeutics, Inc. (NASDAQ:ALLO)
US · Delayed Price · Currency is USD
1.26+0.01 (+0.80%)
Insider Score
––Not scored
ALLO Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ALLO Stock Insider Trading Activity
ALLO stock’s insider trading shows 2 sales on the open market for an estimated $111.66K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Parker Geoffrey M. CFO | Sell | 36,342 | $1.34 | $48.70K | 3.4% | 1,045,877 | Oct 21, 2026 | — | Form 4 |
| Douglas Earl Martin Other | Sell | 29,697 | $2.12 | $62.96K | 5.7% | 488,267 | Aug 21, 2026 | — | Form 4 |
| Kazam Joshua A Director | Option exercise | 47,700 | — | — | 13.6% | 398,463 | Jun 18, 2026 | — | Form 4 |
| Yoshiyama Annie Other | Sell | 9,586 | $2.31 | $22.14K | 7.1% | 124,517 | Apr 21, 2026 | — | Form 4 |
| Beneski Benjamin Machinas Other | Sell | 2,867 | $2.50 | $7.17K | 1.4% | 195,338 | Mar 31, 2026 | — | Form 4 |
| Chang David D CEO | Sell | 47,763 | $2.47 | $117.97K | 0.9% | 5,150,599 | Mar 16, 2026 | — | Form 4 |
| Beneski Benjamin Machinas Other | Sell | 4,835 | $2.47 | $11.94K | 2.4% | 198,205 | Mar 16, 2026 | — | Form 4 |
| Beneski Benjamin Machinas Other | Sell | 7,132 | $2.60 | $18.54K | 3.4% | 203,040 | Mar 2, 2026 | — | Form 4 |
| Yoshiyama Annie Other | Sell | 4,167 | $1.72 | $7.17K | 3.1% | 130,322 | Feb 2, 2026 | — | Form 4 |
| Beneski Benjamin Machinas Other | Sell | 7,549 | $1.73 | $13.06K | 3.5% | 210,172 | Feb 2, 2026 | — | Form 4 |
| Parker Geoffrey M. CFO | Sell | 24,001 | $1.76 | $42.24K | 1.9% | 1,252,795 | Feb 2, 2026 | — | Form 4 |
| Roberts Zachary Other | Sell | 35,700 | $1.77 | $63.19K | 5.8% | 581,166 | Feb 2, 2026 | — | Form 4 |
| Chang David D CEO | Sell | 95,269 | $1.80 | $171.48K | 1.8% | 5,185,862 | Feb 2, 2026 | — | Form 4 |
| Douglas Earl Martin Other | Sell | 22,900 | $1.76 | $40.30K | 3.9% | 564,948 | Feb 2, 2026 | — | Form 4 |
| Roberts Zachary Other | Sell | 26,269 | $1.56 | $40.98K | 4.1% | 616,866 | Jan 21, 2026 | — | Form 4 |
| Kazam Joshua A Director | Option exercise | 47,700 | — | — | 15.7% | 350,763 | Dec 18, 2025 | — | Form 4 |
| Beneski Benjamin Machinas Other | Sell | 786 | $1.22 | $958.92 | 0.4% | 217,721 | Nov 17, 2025 | — | Form 4 |
| Parker Geoffrey M. CFO | Sell | 36,744 | $1.26 | $46.17K | 2.8% | 1,276,796 | Oct 21, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Sell (S) — Open-market or private sale
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.